Zadie, Possibly, but it seems DCVax has a good head start.
Sentiment stocks' post from a few weeks back is worth considering. Monday, April 20, 2026 10:41:10 PM Post# 822134of 824858
Somebody needs to tell DelveInsight.com what the anonymous put-down artists know here on the NWBO ihub board - because their High Grade Glioma report is stating,
By 2036, among all the emerging therapies market sizes of HGG, the highest revenue is expected to be generated by DCVax.
Zadie, this is where $nwbo now being a part of the Parker Institute for Cancer Immunotherapy will pay dividends, in fact only today I posted their new announcement on X.....
"We’re excited to share that Aimee Johnson has joined PICI as Chief Marketing Officer.
A seasoned marketing leader with more than 30 years of experience, Aimee will lead brand, marketing, and digital strategy in support of PICI’s impact and growth. Her leadership will strengthen our ability to amplify our mission and accelerate the development and delivery of breakthrough cancer therapies"
"Her leadership will strengthen our ability to amplify our mission and accelerate the development and delivery of breakthrough cancer therapies" https://t.co/c5rUh7T5yb